The DOI matches its Crossref record; 95 of the 96 references it cites were found in a registry or an index.
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Open accessAbstract
The diagnosis of Alzheimer's disease can be improved by the use of biological measures. Biomarkers of functional impairment, neuronal loss, and protein deposition that can be assessed by neuroimaging (ie, MRI and PET) or CSF analysis are increasingly being used to diagnose Alzheimer's disease in research studies and specialist clinical settings. However, the validation of the clinical usefulness of these biomarkers is incomplete, and that is hampering reimbursement for these tests by health insurance providers, their widespread clinical implementation, and improvements in quality of health care. We have developed a strategic five-phase roadmap to foster the clinical validation of biomarkers in Alzheimer's disease, adapted from the approach for cancer biomarkers. Sufficient evidence of analytical validity (phase 1 of a structured framework adapted from oncology) is available for all biomarkers, but their clinical validity (phases 2 and 3) and clinical utility (phases 4 and 5) are incomplete. To complete these phases, research priorities include the standardisation of the readout of these assays and thresholds for normality, the evaluation of their performance in detecting early disease, the development of diagnostic algorithms comprising combinations of biomarkers, and the development of clinical guidelines for the use of biomarkers in qualified memory clinics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Amyloid PET has been established as an important imaging tool in the early, specific and unbiased diagnosis of AD [153–155].”
From The use of neuroimaging techniques in the early and differential diagnosis of dementia (2023) · cites this paper as [155]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Self-citationAlbert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Self-citationMild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationCurrent concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Self-citationAmyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Self-citationGrundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
Self-citation
Research works printed but not linked: 1
- Alzheimer, 1906, Über einen eigenartigen schweren Erkrankungsprozeß der Hirnrinde, Neurologisches Centralblatt, 23, 1129
Cited by
Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465
Self-citationBlood-based biomarkers for Alzheimer's disease: towards clinical implementation
Teunissen, C. E., Verberk, I. M. W., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00361-6 · Cited by 1,045
Self-citationHigh-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
Schindler, S. E., Bollinger, J. G., Ovod, V., Mawuenyega, K. G., Li, Y., Gordon, B. A., Holtzman, D. M., Morris, J. C., Benzinger, T. L. S., Xiong, C., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008081 · Cited by 885
“This study fits into phases 2 and 3 (out of 5 phases) for validation of plasma Aβ42/Aβ40 as a biomarker for AD, as it evaluates the ability of plasma Aβ42/Aβ40 to detect early AD (in most of the study participants, asymptomatic brain amyloidosis) and explores the effects of covariates on plasma Aβ42/ Aβ40 levels.(43)…”
MethodDiagnosis of Early Alzheimer's Disease: Clinical Practice in 2021
Porsteinsson, A. P., Isaacson, R. S., Knox, S., Sabbagh, M. N., & Rubino, I. (2021) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2021.23 · Cited by 744
“…there is no way to ascertain whether the hypometabolism is directly related to AD pathology (73); however, clinicians may refer patients with more established symptomatology for an FDG-PET scan to identify regions of glucose hypometabolism and neurodegeneration that could be indicative of AD (70).”
InfluentialBasaia, S., Agosta, F., Wagner, L., Canu, E., Magnani, G., Santangelo, R., & Filippi, M. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.101645 · Cited by 738
Metadata
- Authors
- Frisoni, G. B., Boccardi, M., Barkhof, F., Blennow, K., Cappa, S., Chiotis, K., Démonet, J.-F., Garibotto, V., Giannakopoulos, P., Gietl, A., Hansson, O., Herholz, K., Jack, C. R., Nobili, F., Nordberg, A., Snyder, H. M., Ten Kate, M., Varrone, A., Albanese, E., Becker, S., Bossuyt, P., Carrillo, M. C., Cerami, C., Dubois, B., Gallo, V., Giacobini, E., Gold, G., Hurst, S., Lönneborg, A., Lovblad, K.-O., Mattsson, N., Molinuevo, J.-L., Monsch, A. U., Mosimann, U., Padovani, A., Picco, A., Porteri, C., Ratib, O., Saint-Aubert, L., Scerri, C., Scheltens, P., Schott, J. M., Sonni, I., Teipel, S., Vineis, P., Visser, P. J., Yasui, Y., & Winblad, B.
- Affiliations
- University of Geneva (CH)
- UCL Queen Square Institute of Neurology (GB)
- Sahlgrenska University Hospital (SE)
- Istituto Universitario di Studi Superiori di Pavia (IT)
- Region Stockholm (SE)
- University of Zurich (CH)
- Lund University (SE)
- University of Manchester (GB)
- Mayo Clinic (US)
- Ospedale Policlinico San Martino (IT)
- Karolinska University Hospital (SE)
- Alzheimer's Association (US)
- University of Amsterdam (NL)
- Vita-Salute San Raffaele University (IT)
- Pitié-Salpêtrière Hospital (FR)
- Queen Mary University of London (GB)
- Felix Platter-Hospital (CH)
- University of Bern (CH)
- University of Brescia (IT)
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- University Hospital of Geneva (CH)
- University of Malta (MT)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- German Center for Neurodegenerative Diseases (DE)
- Imperial College London (GB)
- Maastricht University (NL)
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Frisoni, Giovanni B
- ORCID
- Frisoni, Giovanni B
- Boccardi, Marina
- Barkhof, Frederik
- Blennow, Kaj
- Cappa, Stefano
- Chiotis, Konstantinos
- Garibotto, Valentina
- Gietl, Anton
- Hansson, Oskar
- Herholz, Karl
- Jack, Clifford R
- Nobili, Flavio
- Nordberg, Agneta
- Snyder, Heather M
- Varrone, Andrea
- Albanese, Emiliano
- Becker, Stefanie
- Bossuyt, Patrick
- Cerami, Chiara
- Dubois, Bruno
- Gallo, Valentina
- Hurst, Samia
- Mattsson, Niklas
- Monsch, Andreas U
- Mosimann, Urs
- Padovani, Alessandro
- Picco, Agnese
- Porteri, Corinna
- Ratib, Osman
- Scerri, Charles
- Scheltens, Philip
- Schott, Jonathan M
- Sonni, Ida
- Teipel, Stefan
- Vineis, Paolo
- Visser, Pieter Jelle
- Yasui, Yutaka
- Winblad, Bengt
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 16
- Issue
- 8
- Pages
- 661-676
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2736213625
- Cited by
- 626
- References
- 96
- Citations by year
- 2026: 42 · 2025: 48 · 2024: 65 · 2023: 79 · 2022: 80 · 2021: 83 · 2020: 76 · 2019: 65 · 2018: 73 · 2017: 13
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- green
- qmro.qmul.ac.uk
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- edoc (University of Basel) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- IRIS (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- DZNE Pub (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by-nc-nd)
- SERVAL (Université de Lausanne) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Medical Research Council (MR/L023784/2)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, early diagnosis, biomarkers, biomarker validation, clinical validation, analytical validity, clinical validity, clinical utility, neuroimaging biomarkers, cerebrospinal fluid biomarkers, diagnostic algorithm, memory clinics, health insurance reimbursement, research priorities
- MeSH terms
- Alzheimer Disease, Humans, Biomarkers, Early Diagnosis, Validation Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. https://app.cochat.ai/papers/10.1016/s1474-4422(17)30159-x
- The paper
- Frisoni, G. B., Boccardi, M., Barkhof, F., Blennow, K., Cappa, S., Chiotis, K., Démonet, J.-F., Garibotto, V., Giannakopoulos, P., Gietl, A., Hansson, O., Herholz, K., Jack, C. R., Nobili, F., Nordberg, A., Snyder, H. M., Ten Kate, M., Varrone, A., Albanese, E., . . . Winblad, B. (2017). Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(17)30159-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.